Sodium-glucose cotransporter-2 inhibitors may be linked to Fournier gangrene
1. In this descriptive case series, 55 cases of patients with diabetes who developed Fournier gangrene while using sodium-glucose cotransporter-2 ...
Tag: sglt2 inhibitors
Canagliflozin reduces cardiovascular outcomes in patients with diabetes: The CANVAS
1. Canagliflozin, a sodium glucose cotransporter 2 (SGLT2) inhibitor, significantly reduced the risk of the primary composite outcome of cardiovascular ...
Empagliflozin reduces the risk of long-term renal effects in type 2 diabetes
1. In patients with type 2 diabetes and an estimated glomerular filtration (eGFR) rate of ≥ 30 mL per minute ...